Physiologic levels of 3,3',5'-triiodothyronine (rT3) are generally believed to have minimal metabolic effects in the pituitary gland and other tissues. In the present studies, the regulatory role of rT3 and other thyroid hormones on iodothyronine 5'-deiodinase (15D) activity was studied in a growth hormoneproducing rat pituitary tumor cell line (GH3 cells). O5D activity was thiol-dependent and displayed nonlinear reaction kinetics suggesting the presence of two enzymatic processes, one having a low Michaelis constant (K. for thyroxine IT41 of 2 nM) and a second with a high K. value (0.9 MM). Growth of cells in hormone-depleted medium resulted in a two-to 3.5-fold increase in low K. 151D activity (P < 0.001). The addition of thyroid hormones to the culture medium resulted in a rapid, dosedependent inhibition of low K. 151) activity with the following order of analogue potency: rT3 2 T4> 3,5,3'-triiodothyronine (T3). Using serum-free culture conditions rT3 was -50 times more active than Tj. These inhibitory effects were noted within 15 min of hormone addition and could not be attributed to substrate competition with T4. These findings suggest that the control of T4 to T3 conversion by thyroid hormones in the anterior pituitary gland is mediated by a unique cellular mechanism that is independent of the nuclear T3 receptor, and under some circumstances, rT3 may play a regulatory role in controlling this enzymatic process.
Introduction
The metabolic actions of thyroid hormones appear to be mediated primarily through the interaction of 3,5,3'-triiodothyronine (T3) with specific nuclear receptors (1) . In the various growth hormone-producing rat pituitary tumor cell lines (GH cells) for example, T3 is the most potent thyroid hormone analogue in stimulating glucose consumption (2) , growth hormone production (3), and amino acid transport (4) , and these effects correlate well with the proportion of nuclear binding sites occupied by T3. Although 3,3',5Y-triiodothyronine (rT3) also has agonist activity in GH cells, 1,000-fold greater concentrations are required, presumably due to the nuclear receptor having a significantly lower affinity for rT3 (5) . In other systems, the metabolic effects ofrT3 also appear to be minimal (5) .
In the present studies, we used the GH3 cell line to investigate the regulatory effects of thyroid hormones on a low Michaelis constant (Ki) iodothyronine 5'-deiodinase (I51D) process (type II). Our finding that rT3 is a potent and rapid inhibitor of this enzymatic process suggests that thyroid hormone control of T3 formation in anterior pituitary tissue is mediated through a unique cellular mechanism that is independent of the nuclear T3 receptor.
Methods
GH3 cells were obtained from the American Type Culture Collection (Rockville, MD) and were routinely grown in 75-cm2 plastic flasks and 100-mm plastic culture dishes using Ham's F-10 culture medium supplemented with 2.5% fetal calf serum (FCS), 15% horse serum (HS), and gentamycin (50 usg/ml) in a humidified atmosphere of 5% C02/95% air. Medium was routinely changed twice weekly. In some experiments cells were grown to near confluence in standard medium and then transferred and maintained for 4 d in serum-free Ham's F-10 or in Ham's F-10 supplemented with FCS (10%) that previously had been treated with either charcoal (6) or an ion exchange resin (7 Several experiments were performed to characterize and define the optimal conditions for quantifying 15)D activity in GH3 cells: (a) enzyme activity in supernatants was found to be a linear function of both protein concentration (up to 11 mg/ml) and incubation time (up to 45 min) and was dependent on the presence of sulflhydryl reducing agents (maximum activity at 20 mM DTT). The uptake of rT3 by GH3 cells was determined by incubating cells in medium containing a known specific activity of '25I-rT3 (New England Nuclear, Boston, MA). Cells were then harvested, washed, and sonicated as above, and the amount of radioactivity in the supernate fraction was determined. The rT3 content was calculated after correcting for the proportion of counts due to "25I as determined by electrophoresis (11) . Stable rT3 was obtained from CalbiochemBehring Corp., La Jolla, CA.
Kinetic data were analyzed using Eadie-Hofstee plots, and nonlinear plots were resolved into two components as previously described (9) . Statistical comparison was performed using the unpaired t test. All results are given as mean±SE.
Results
151D activity in GH3 cell supernatants demonstrated nonlinear reaction kinetics suggesting the presence of two enzymatic processes having Km values of 2.4±1.0 nM (n = 4 experiments) and 0.9±0.3 /iM (Fig. 1) . Corresponding values for the maximum velocity were 23±7 fmol T3/min mg protein and 32±6 fmol T3/min mg protein. The addition of 0.5 mM 6-n-propyl-2-thiouracil to cell sonicates (in the presence of 5 mM DTT) inhibited T3 production by <10% at low substrate concentrations (10 nM T4) but by 53% (P < 0.001) at T4 concentrations of 3 ,M (data not shown). In subsequent experiments 15'D activity was determined using supernatant substrate concentrations of 10 Figure 2 . The effect of different medium conditions on 151) activity in GH3 cells. Cells were grown to near confluence in standard medium (FCS/HS) and then transferred and maintained for four additional days in the medium indicated. 15D activity was determined using a T4 concentration of 10 nM and 20 mM DTT. Values represent the mean±SE of triplicate determinations. ., P < 0.001 compared with cells maintained in untreated FCS. Prot, protein.
charcoal-treated FCS showed a two-to 3.5-fold increase in I5'D activity, suggesting that one or more components of serum exerted inhibitory effects on enzyme activity. The addition of T4, T3, or rT3 to the culture medium resulted in significant inhibitory effects on 15'D activity. Dose response curves, as determined in serum-free medium, are shown in Fig. 3 . In this experiment, rT3 was somewhat more active than T4 and 50 times more active than T3 in inhibiting 151D activity. Additional experiments (n = 5) using both serum-free conditions and medium supplemented with resin-treated FCS confirmed that the order of potency of these analogues was rT3 . T4 > T3. In medium supplemented with resin-treated FCS, T3 concentrations of >lO-' M were required to inhibit 151D activity. Thyronine, at concentrations up to 10-7 M, inhibited this process by <10%.
The potential of rT3 acting as a competitive substrate with T4 in the reaction mixture was assessed by determining the rate of T3 formation in the presence of both added T4 (50 nM) and rTi3. Concentrations of rT3 of up to 1O nM had no effect on T3 production rates. Quantitation of rT3 cellular uptake revealed that 4 h after the addition of 10-8 M rT3 to the culture medium, supernatant concentrations of rT3 were -5 nM in cells grown in serum-free medium and 0.4 nM in cells maintained in medium supplemented with resin-treated FCS. Thus, even at high medium rT3 concentrations, the supernatant concentrations of rT3 were insufficient to affect T3 production rates when 50 nM T4 was provided as substrate in the reaction mixture. Furthermore, the concentration of T4 (as determined by RIA) in supernatants derived from cells grown in medium supplemented with resin-treated FCS and either 10-8 M or 10-' M T4 were 0.7 nM and 7 nM, respectively; concentrations that would not add significantly to the rates of T3 formation in the reaction mixture. The regulatory effect of rT3 on 15D activity was shown to be quite rapid (Fig. 4) . Significant inhibition was noted within 15 min of adding rT3 to the medium and was near maximal at 2 h. A similar time course of inhibition was shown for T4. Discussion I5'D activity in GH3 cells was shown in the present studies to be a thiol-dependent process with nonlinear reaction kinetics suggesting the presence of two enzymatic pathways having markedly different Km values for T4. A differential sensitivity of these two processes to the inhibitory effects of PTU was also noted, These findings are similar to those previously described in homogenates of rat anterior pituitary glands (9, 13) and cerebral cortex (14) . Our findings differ, however, from a prior report using GH3 cells where only a high Km process (3.8 MM) was identified (15). The failure to detect a low Km process in this latter study may have been secondary to the low concentrations of DTT used (2 mM) and the relative insensitivity of the T3 RIA (3.75 pg/tube lower limits of detection vs. 0.2 pg/tube in the present studies [8, 91) .
Recent studies have shown that low Km 151D activity is responsible for the vast majority of "local" T3 formation in the pituitary and depends on thyroid hormone status (8, 13 (17) . The suppressive effects of thyroid hormones on low Km (type II) 151) activity in GH3 cells, however, cannot be attributed to this mechanism. Our demonstration that rT3 is a potent inhibitor of this process contrasts sharply with the weak agonist activity ofthis analogue on other metabolic processes (2, 5) and strongly suggests that a unique regulatory mechanism, independent of the nuclear T3 receptor, is responsible for this effect. Further evidence for this is the finding that relatively high concentrations of T3 (10-9 M in medium containing serum), which have been shown by other investigators to stimulate significantly growth hormone production and maximally suppress thyrotropinreleasing hormone receptors in GH3 cells (18) , had no effect on 15D activity. A recent report (19) demonstrating that the injection of T4 or rT3 in the rat is more effective than T3 in inhibiting pituitary and cerebral cortex I5D activity, suggests that the order of iodothyronine potency found in GH3 cells is also applicable in vivo. The cellular processes responsible for these regulatory effects are uncertain. Leonard et al. (20) , however, have recently suggested that the T3-dependent inhibition of 15D activity in rat pituitary and cerebral cortex is mediated by a posttranscriptional mechanism that increases the rate of degradation or inactivation of the enzyme.
To date, a 5-deiodinase process has not been described in pituitary tissue and none could be demonstrated in the present study in GH3 cells when T3 was used as a substrate. This finding, together with the near equal potency of T4 with rT3, suggests that the regulatory effects of T4 on 15D activity are direct and not mediated by conversion to rT3.
An intriguing question raised by these studies is the possible role of rT3 in the control of T4 to T3 conversion in the pituitary and brain. Although rT3 appears to be a potent regulator of this metabolic process, its free concentration in normal human serum is '40-fold lower than that of T4 (21).
Thus, T4 rather than rT3 is likely to exert the principle physiologic control over this process. This thesis is consistent with reports that the administration of rT3 to normal human subjects has no effect on the serum levels of T4, T3, thyrotropin, or the thyrotropin response to thyrotropin-releasing hormone (22, 23) . In nonthyroidal illness, however, marked alterations occur in thyroid hormone metabolism, which may result in decreased serum free T4 levels and increases in serum free rT3 levels of up to 15-fold (21). Under such circumstances, inhibitory effects of rT3 on 151D activity may become significant.
